Emend for injection,
fosaprepitant,
fosaprepitant dimeglumine,
L 785,298,
L-785,298,
L785,298,
Fosaprepitant dimeglumine,
265121-04-8,
Fosaprepitant dimeglumine salt,
Fosaprepitant (dimeglumine),
UNII-D35FM8T64X,
Ivemend,
MK-0517,
D35FM8T64X,
CHEBI:64311,
Fosaprepitant dimeglumine [USAN],
Fosaprepitant dimeglumine (USAN),
L-758298,
Proemend (TN),
Fosaprepitant meglumine,
Fosaprepitant meglumine (JAN),
CHEMBL1201782,
DTXSID50181095,
VRQHBYGYXDWZDL-OOZCZQCLSA-N,
EX-A1255,
HY-14407A,
AKOS025401855,
AKOS026751492,
ACN-037209,
CS-1761,
C23H22F7N4O6P.2C7H17NO5,
AC-26397,
SC-94648,
FT-0668862,
SW219389-1,
X3475,
D06597,
J-521390,
(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol hemi((3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate),
(3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid--1-deoxy-1-(methylamino)-D-glucitol (1/2),
bis[1-deoxy-1-(methylazaniumyl)-D-glucitol] (3-{[(2R,3S)-2-{(1R,)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate,
D-Glucitol, 1-deoxy-1-(methylamino)-, (3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4- morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)phosphonate (2:1) (salt),
Phosphonic acid, (3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:2),
Fosaprepitant,
Emend,
A11069,